This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

March 14-17, 2022
San Diego Convention CenterSan Diego, California

Vigene Biosciences


Learn more about Vigene Biosciences and our advances in the bioprocessing industry. Be sure to join our exciting panel discussion on Cell & Gene Therapy Analytics with Jeff Hung, Vigene’s Chief Commercial Officer, David Dobnik, National Institute of Biology, and Shawn Liu, Avirmax Inc.

Vigene Biosciences is an award-winning world leader in plasmid and viral vector development and manufacturing. Vigene features integrated plasmid and viral vector production and analytical service offerings from its 110,000 sq ft of state-of-the-art facility with over 15 GMP cleanroom suites. Vigene’s mission is to make gene therapy affordable. On basic research side, Vigene is developing, manufacturing, and distributing state-of-the-art AAV, lentivirus, retrovirus, adenovirus, and plasmid-based reagents including HHMI/Janelia Research Campus AAV Biosensors. On the cGMP clinical production side, Vigene combines the proven production technologies with rigorous regulatory compliant cGMP production to meet the needs and expectations of clinical and commercial clients. Vigene offers FDA and EMA compliant cGMP production for AAV, lentivirus, adenovirus, retrovirus, and plasmids to global pharmaceutical and biotech companies, governmental agencies and non-profit organizations.

Vigene Biosciences Homepage:

Contact us:

Dr. Jeff Hung, Presenter and Chief Commercial Officer

5 Research Court, Rockville, MD 20850


Pat DePalma, VP of Business Development

5 Research Court, Rockville, MD 20850


We're bringing you

  • Panel: Cell & Gene Therapy Analytics